Copyright Reports & Markets. All rights reserved.

Global Anti-Infective Ophthalmic Market Insights and Forecast to 2027

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Anti-Infective Ophthalmic Product Introduction
  • 1.2 Market by Type
    • 1.2.1 Global Anti-Infective Ophthalmic Market Size Growth Rate by Type
    • 1.4.2 Antibacterial
    • 1.4.3 Antiviral
    • 1.2.4 Antifungal
    • 1.2.5 Anti-Parasitic
    • 1.2.6 Others
  • 1.3 Market by Application
    • 1.3.1 Global Anti-Infective Ophthalmic Market Size Growth Rate by Application
    • 1.3.2 Hospital
    • 1.3.3 Clinic
    • 1.3.4 Household
    • 1.3.5 Others
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Executive Summary

  • 2.1 Global Anti-Infective Ophthalmic Sales Estimates and Forecasts 2016-2027
  • 2.2 Global Anti-Infective Ophthalmic Revenue Estimates and Forecasts 2016-2027
  • 2.3 Global Anti-Infective Ophthalmic Revenue by Region: 2016 VS 2021 VS 2027
  • 2.4 Global Top Anti-Infective Ophthalmic Regions by Sales
    • 2.4.1 Global Top Anti-Infective Ophthalmic Regions by Sales (2016-2021)
    • 2.4.2 Global Top Anti-Infective Ophthalmic Regions by Sales (2022-2027)
  • 2.5 Global Top Anti-Infective Ophthalmic Regions by Revenue
    • 2.5.1 Global Top Anti-Infective Ophthalmic Regions by Revenue (2016-2021)
    • 2.5.2 Global Top Anti-Infective Ophthalmic Regions by Revenue (2022-2027)
  • 2.6 North America
  • 2.7 Europe
  • 2.8 Asia-Pacific
  • 2.9 Latin America
  • 2.10 Middle East & Africa

3 Competition by Manufacturers

  • 3.1 Global Anti-Infective Ophthalmic Sales by Manufacturers
    • 3.1.1 Global Top Anti-Infective Ophthalmic Manufacturers by Sales (2016-2021)
    • 3.1.2 Global Top Anti-Infective Ophthalmic Manufacturers Market Share by Sales (2016-2021)
    • 3.1.3 Global Top 10 and Top 5 Companies by Anti-Infective Ophthalmic Sales in 2020
  • 3.2 Global Anti-Infective Ophthalmic Revenue by Manufacturers
    • 3.2.1 Global Top Anti-Infective Ophthalmic Manufacturers by Revenue (2016-2021)
    • 3.2.2 Global Top Anti-Infective Ophthalmic Manufacturers Market Share by Revenue (2016-2021)
    • 3.2.3 Global Top 10 and Top 5 Companies by Anti-Infective Ophthalmic Revenue in 2020
  • 3.3 Global Anti-Infective Ophthalmic Sales Price by Manufacturers
  • 3.4 Analysis of Competitive Landscape
    • 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Anti-Infective Ophthalmic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 3.4.3 Global Anti-Infective Ophthalmic Manufacturers Geographical Distribution
  • 3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

  • 4.1 Global Anti-Infective Ophthalmic Sales by Type
    • 4.1.1 Global Anti-Infective Ophthalmic Historical Sales by Type (2016-2021)
    • 4.1.2 Global Anti-Infective Ophthalmic Forecasted Sales by Type (2022-2027)
    • 4.1.3 Global Anti-Infective Ophthalmic Sales Market Share by Type (2016-2027)
  • 4.2 Global Anti-Infective Ophthalmic Revenue by Type
    • 4.2.1 Global Anti-Infective Ophthalmic Historical Revenue by Type (2016-2021)
    • 4.2.2 Global Anti-Infective Ophthalmic Forecasted Revenue by Type (2022-2027)
    • 4.2.3 Global Anti-Infective Ophthalmic Revenue Market Share by Type (2016-2027)
  • 4.3 Global Anti-Infective Ophthalmic Price by Type
    • 4.3.1 Global Anti-Infective Ophthalmic Price by Type (2016-2021)
    • 4.3.2 Global Anti-Infective Ophthalmic Price Forecast by Type (2022-2027)

5 Market Size by Application

  • 5.1 Global Anti-Infective Ophthalmic Sales by Application
    • 5.1.1 Global Anti-Infective Ophthalmic Historical Sales by Application (2016-2021)
    • 5.1.2 Global Anti-Infective Ophthalmic Forecasted Sales by Application (2022-2027)
    • 5.1.3 Global Anti-Infective Ophthalmic Sales Market Share by Application (2016-2027)
  • 5.2 Global Anti-Infective Ophthalmic Revenue by Application
    • 5.2.1 Global Anti-Infective Ophthalmic Historical Revenue by Application (2016-2021)
    • 5.2.2 Global Anti-Infective Ophthalmic Forecasted Revenue by Application (2022-2027)
    • 5.2.3 Global Anti-Infective Ophthalmic Revenue Market Share by Application (2016-2027)
  • 5.3 Global Anti-Infective Ophthalmic Price by Application
    • 5.3.1 Global Anti-Infective Ophthalmic Price by Application (2016-2021)
    • 5.3.2 Global Anti-Infective Ophthalmic Price Forecast by Application (2022-2027)

6 North America

  • 6.1 North America Anti-Infective Ophthalmic Market Size by Type
    • 6.1.1 North America Anti-Infective Ophthalmic Sales by Type (2016-2027)
    • 6.1.2 North America Anti-Infective Ophthalmic Revenue by Type (2016-2027)
  • 6.2 North America Anti-Infective Ophthalmic Market Size by Application
    • 6.2.1 North America Anti-Infective Ophthalmic Sales by Application (2016-2027)
    • 6.2.2 North America Anti-Infective Ophthalmic Revenue by Application (2016-2027)
  • 6.3 North America Anti-Infective Ophthalmic Market Size by Country
    • 6.3.1 North America Anti-Infective Ophthalmic Sales by Country (2016-2027)
    • 6.3.2 North America Anti-Infective Ophthalmic Revenue by Country (2016-2027)
    • 6.3.3 U.S.
    • 6.3.4 Canada

7 Europe

  • 7.1 Europe Anti-Infective Ophthalmic Market Size by Type
    • 7.1.1 Europe Anti-Infective Ophthalmic Sales by Type (2017-2027)
    • 7.1.2 Europe Anti-Infective Ophthalmic Revenue by Type (2017-2027)
  • 7.2 Europe Anti-Infective Ophthalmic Market Size by Application
    • 7.2.1 Europe Anti-Infective Ophthalmic Sales by Application (2017-2027)
    • 7.2.2 Europe Anti-Infective Ophthalmic Revenue by Application (2017-2027)
  • 7.3 Europe Anti-Infective Ophthalmic Market Size by Country
    • 7.3.1 Europe Anti-Infective Ophthalmic Sales by Country (2017-2027)
    • 7.3.2 Europe Anti-Infective Ophthalmic Revenue by Country (2017-2027)
    • 7.3.3 Germany
    • 7.3.4 France
    • 7.3.5 U.K.
    • 7.3.6 Italy
    • 7.3.7 Russia

8 Asia Pacific

  • 8.1 Asia Pacific Anti-Infective Ophthalmic Market Size by Type
    • 8.1.1 Asia Pacific Anti-Infective Ophthalmic Sales by Type (2018-2027)
    • 8.1.2 Asia Pacific Anti-Infective Ophthalmic Revenue by Type (2018-2027)
  • 8.2 Asia Pacific Anti-Infective Ophthalmic Market Size by Application
    • 8.2.1 Asia Pacific Anti-Infective Ophthalmic Sales by Application (2018-2027)
    • 8.2.2 Asia Pacific Anti-Infective Ophthalmic Revenue by Application (2018-2027)
  • 8.3 Asia Pacific Anti-Infective Ophthalmic Market Size by Region
    • 8.3.1 Asia Pacific Anti-Infective Ophthalmic Sales by Region (2018-2027)
    • 8.3.2 Asia Pacific Anti-Infective Ophthalmic Revenue by Region (2018-2027)
    • 8.3.3 China
    • 8.3.4 Japan
    • 8.3.5 South Korea
    • 8.3.6 India
    • 8.3.7 Australia
    • 8.3.8 Taiwan
    • 8.3.9 Indonesia
    • 8.3.10 Thailand
    • 8.3.11 Malaysia
    • 8.3.12 Philippines

9 Latin America

  • 9.1 Latin America Anti-Infective Ophthalmic Market Size by Type
    • 9.1.1 Latin America Anti-Infective Ophthalmic Sales by Type (2019-2027)
    • 9.1.2 Latin America Anti-Infective Ophthalmic Revenue by Type (2019-2027)
  • 9.2 Latin America Anti-Infective Ophthalmic Market Size by Application
    • 9.2.1 Latin America Anti-Infective Ophthalmic Sales by Application (2019-2027)
    • 9.2.2 Latin America Anti-Infective Ophthalmic Revenue by Application (2019-2027)
  • 9.3 Latin America Anti-Infective Ophthalmic Market Size by Country
    • 9.3.1 Latin America Anti-Infective Ophthalmic Sales by Country (2019-2027)
    • 9.3.2 Latin America Anti-Infective Ophthalmic Revenue by Country (2019-2027)
    • 9.3.3 Mexico
    • 9.3.4 Brazil
    • 9.3.5 Argentina

6 Middle East and Africa

  • 6.1 Middle East and Africa Anti-Infective Ophthalmic Market Size by Type
    • 6.1.1 Middle East and Africa Anti-Infective Ophthalmic Sales by Type (2016-2027)
    • 6.1.2 Middle East and Africa Anti-Infective Ophthalmic Revenue by Type (2016-2027)
  • 6.2 Middle East and Africa Anti-Infective Ophthalmic Market Size by Application
    • 6.2.1 Middle East and Africa Anti-Infective Ophthalmic Sales by Application (2016-2027)
    • 6.2.2 Middle East and Africa Anti-Infective Ophthalmic Revenue by Application (2016-2027)
  • 6.3 Middle East and Africa Anti-Infective Ophthalmic Market Size by Country
    • 6.3.1 Middle East and Africa Anti-Infective Ophthalmic Sales by Country (2016-2027)
    • 6.3.2 Middle East and Africa Anti-Infective Ophthalmic Revenue by Country (2016-2027)
    • 6.3.3 Turkey
    • 6.3.4 Saudi Arabia
    • 6.3.5 U.A.E

11 Company Profiles

  • 11.1 Novartis
    • 11.1.1 Novartis Corporation Information
    • 11.1.2 Novartis Overview
    • 11.1.3 Novartis Anti-Infective Ophthalmic Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.1.4 Novartis Anti-Infective Ophthalmic Product Description
    • 11.1.5 Novartis Related Developments
  • 11.2 Allergan
    • 11.2.1 Allergan Corporation Information
    • 11.2.2 Allergan Overview
    • 11.2.3 Allergan Anti-Infective Ophthalmic Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.2.4 Allergan Anti-Infective Ophthalmic Product Description
    • 11.2.5 Allergan Related Developments
  • 11.3 Bausch Health
    • 11.3.1 Bausch Health Corporation Information
    • 11.3.2 Bausch Health Overview
    • 11.3.3 Bausch Health Anti-Infective Ophthalmic Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.3.4 Bausch Health Anti-Infective Ophthalmic Product Description
    • 11.3.5 Bausch Health Related Developments
  • 11.4 Santen Pharmaceutical
    • 11.4.1 Santen Pharmaceutical Corporation Information
    • 11.4.2 Santen Pharmaceutical Overview
    • 11.4.3 Santen Pharmaceutical Anti-Infective Ophthalmic Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.4.4 Santen Pharmaceutical Anti-Infective Ophthalmic Product Description
    • 11.4.5 Santen Pharmaceutical Related Developments
  • 11.5 Lupin Pharmaceuticals
    • 11.5.1 Lupin Pharmaceuticals Corporation Information
    • 11.5.2 Lupin Pharmaceuticals Overview
    • 11.5.3 Lupin Pharmaceuticals Anti-Infective Ophthalmic Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.5.4 Lupin Pharmaceuticals Anti-Infective Ophthalmic Product Description
    • 11.5.5 Lupin Pharmaceuticals Related Developments
  • 11.6 Apotex
    • 11.6.1 Apotex Corporation Information
    • 11.6.2 Apotex Overview
    • 11.6.3 Apotex Anti-Infective Ophthalmic Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.6.4 Apotex Anti-Infective Ophthalmic Product Description
    • 11.6.5 Apotex Related Developments
  • 11.7 Akorn
    • 11.7.1 Akorn Corporation Information
    • 11.7.2 Akorn Overview
    • 11.7.3 Akorn Anti-Infective Ophthalmic Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.7.4 Akorn Anti-Infective Ophthalmic Product Description
    • 11.7.5 Akorn Related Developments
  • 11.1 Novartis
    • 11.1.1 Novartis Corporation Information
    • 11.1.2 Novartis Overview
    • 11.1.3 Novartis Anti-Infective Ophthalmic Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.1.4 Novartis Anti-Infective Ophthalmic Product Description
    • 11.1.5 Novartis Related Developments

12 Value Chain and Sales Channels Analysis

  • 12.1 Anti-Infective Ophthalmic Value Chain Analysis
  • 12.2 Anti-Infective Ophthalmic Key Raw Materials
    • 12.2.1 Key Raw Materials
    • 12.2.2 Raw Materials Key Suppliers
  • 12.3 Anti-Infective Ophthalmic Production Mode & Process
  • 12.4 Anti-Infective Ophthalmic Sales and Marketing
    • 12.4.1 Anti-Infective Ophthalmic Sales Channels
    • 12.4.2 Anti-Infective Ophthalmic Distributors
  • 12.5 Anti-Infective Ophthalmic Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

  • 13.1 Anti-Infective Ophthalmic Industry Trends
  • 13.2 Anti-Infective Ophthalmic Market Drivers
  • 13.3 Anti-Infective Ophthalmic Market Challenges
  • 13.4 Anti-Infective Ophthalmic Market Restraints

14 Key Findings in The Global Anti-Infective Ophthalmic Study

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Author Details

    Anti-Infective Ophthalmic market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Anti-Infective Ophthalmic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

    Segment by Type
    Antibacterial
    Antiviral
    Antifungal
    Anti-Parasitic
    Others

    Segment by Application
    Hospital
    Clinic
    Household
    Others

    By Company
    Novartis
    Allergan
    Bausch Health
    Santen Pharmaceutical
    Lupin Pharmaceuticals
    Apotex
    Akorn

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia

    Buy now